IN8bio (INAB) Competitors $0.29 +0.01 (+4.00%) As of 01/3/2025 05:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INAB vs. SKYE, AADI, ZIVO, ANVS, IMRX, GALT, ONCY, GBIO, INCR, and TLSAShould you be buying IN8bio stock or one of its competitors? The main competitors of IN8bio include Skye Bioscience (SKYE), Aadi Bioscience (AADI), ZIVO Bioscience (ZIVO), Annovis Bio (ANVS), Immuneering (IMRX), Galectin Therapeutics (GALT), Oncolytics Biotech (ONCY), Generation Bio (GBIO), InterCure (INCR), and Tiziana Life Sciences (TLSA). These companies are all part of the "pharmaceutical products" industry. IN8bio vs. Skye Bioscience Aadi Bioscience ZIVO Bioscience Annovis Bio Immuneering Galectin Therapeutics Oncolytics Biotech Generation Bio InterCure Tiziana Life Sciences IN8bio (NASDAQ:INAB) and Skye Bioscience (NASDAQ:SKYE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, community ranking, profitability and dividends. Do institutionals & insiders have more ownership in INAB or SKYE? 92.1% of IN8bio shares are owned by institutional investors. Comparatively, 21.1% of Skye Bioscience shares are owned by institutional investors. 15.5% of IN8bio shares are owned by company insiders. Comparatively, 3.0% of Skye Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is INAB or SKYE more profitable? Skye Bioscience's return on equity of -45.78% beat IN8bio's return on equity.Company Net Margins Return on Equity Return on Assets IN8bioN/A -197.15% -130.48% Skye Bioscience N/A -45.78%-37.44% Does the media favor INAB or SKYE? In the previous week, IN8bio had 1 more articles in the media than Skye Bioscience. MarketBeat recorded 1 mentions for IN8bio and 0 mentions for Skye Bioscience. IN8bio's average media sentiment score of 0.98 beat Skye Bioscience's score of 0.00 indicating that IN8bio is being referred to more favorably in the media. Company Overall Sentiment IN8bio Positive Skye Bioscience Neutral Does the MarketBeat Community favor INAB or SKYE? IN8bio received 24 more outperform votes than Skye Bioscience when rated by MarketBeat users. CompanyUnderperformOutperformIN8bioOutperform Votes2472.73% Underperform Votes927.27% Skye BioscienceN/AN/A Which has more volatility and risk, INAB or SKYE? IN8bio has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Comparatively, Skye Bioscience has a beta of 1.72, meaning that its share price is 72% more volatile than the S&P 500. Do analysts rate INAB or SKYE? IN8bio currently has a consensus target price of $7.75, indicating a potential upside of 2,559.57%. Skye Bioscience has a consensus target price of $18.67, indicating a potential upside of 554.97%. Given IN8bio's higher possible upside, analysts plainly believe IN8bio is more favorable than Skye Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IN8bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Skye Bioscience 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, INAB or SKYE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIN8bioN/AN/A-$30.01M-$0.75-0.39Skye BioscienceN/AN/A-$37.65MN/AN/A SummaryIN8bio beats Skye Bioscience on 7 of the 11 factors compared between the two stocks. Get IN8bio News Delivered to You Automatically Sign up to receive the latest news and ratings for INAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INAB vs. The Competition Export to ExcelMetricIN8bioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.12M$2.95B$5.21B$9.05BDividend YieldN/A1.91%4.99%4.14%P/E Ratio-0.3946.1687.7717.30Price / SalesN/A444.131,156.86124.24Price / CashN/A174.7543.2637.86Price / Book0.505.855.185.19Net Income-$30.01M-$41.30M$121.70M$226.98M7 Day Performance7.93%3.46%3.68%3.15%1 Month Performance-3.25%0.94%21.16%4.46%1 Year Performance-79.04%11.49%30.67%21.92% IN8bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INABIN8bio3.4205 of 5 stars$0.29+4.0%$7.75+2,559.6%-79.0%$21.12MN/A-0.3920Gap UpSKYESkye Bioscience1.2107 of 5 stars$2.46-7.5%$18.67+658.8%+10.0%$74.63MN/A0.0011AADIAadi Bioscience1.386 of 5 stars$3.02-5.9%$1.67-44.8%+77.2%$74.43M$25.07M-1.3240Positive NewsZIVOZIVO BioscienceN/A$20.89-2.2%N/A+672.9%$74.08M$15,850.00-4.2810News CoverageGap DownANVSAnnovis Bio2.1511 of 5 stars$5.28+0.2%$31.40+494.7%-67.0%$72.85MN/A-1.183IMRXImmuneering3.2814 of 5 stars$2.33flat$12.80+449.4%-65.4%$72.35M$320,000.00-1.1860Positive NewsGALTGalectin Therapeutics1.6477 of 5 stars$1.15flat$11.00+856.5%-30.1%$72.18MN/A-1.589High Trading VolumeONCYOncolytics Biotech1.4727 of 5 stars$0.92-7.4%$4.00+334.8%-26.7%$71.26MN/A-3.4130GBIOGeneration Bio3.3744 of 5 stars$1.07-0.5%$7.50+604.2%-39.5%$71.14M$18.58M-0.49150INCRInterCureN/A$1.56-4.1%N/A+21.8%$71.09M$272.67M0.00350Gap UpTLSATiziana Life Sciences1.2123 of 5 stars$0.67-0.1%N/A+21.9%$70.83MN/A0.008 Related Companies and Tools Related Companies SKYE Competitors AADI Competitors ZIVO Competitors ANVS Competitors IMRX Competitors GALT Competitors ONCY Competitors GBIO Competitors INCR Competitors TLSA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INAB) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
